JONATHAN BRIGGS: Open Payments
NPI 1053380220 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$296 in 17 payments from 8 companies in 2025. Trend: 2023 $128 · 2024 $152 · 2025 $296
Food & beverage: $296
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Novo Nordisk Inc | 3 | $68 |
| Dexcom, Inc. | 2 | $49 |
| Phathom Pharmaceuticals, Inc. | 3 | $32 |
| ABBVIE INC. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| PFIZER INC. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: FARXIGA, Dexcom G6 Transmitter, Rybelsus, AIRSUPRA, VOQUEZNA, Ozempic, UBRELVY, SHINGRIX.
Industry payments across SC — which companies pay providers there.
